CAS 480998-12-7

Mc-doxhzn hydrochloride

CAS : 480998-12-7

Mc-doxhzn hydrochloride is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) and inhibits its signaling. It is used in the treatment of cancer, especially of tissue sarcoma. Mc-doxhzn hydrochloride has been shown to be an effective therapy for chordoma, a type of cancerous tumor, when combined with ifosfamide. This drug's affinity for EGFR may also be therapeutic for other types of cancers that over-express this receptor. Mc-doxhzn hydrochloride can bind to the cell surface receptor CD20 on B cells and inhibit their proliferation by triggering apoptosis or programmed cell death.

Formule : C₃₇H₄₂N₄O₁₃•HCl

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 787.21 g/mol

Ref: 3D-FUA99812

MC-DOXHZN hydrochloride

CAS : 480998-12-7

MC-DOXHZN hydrochloride is an albumin-binding prodrug of Doxorubicin. Doxorubicin is a DNA topoisomerase II inhibitor.

Formule : C₃₇H₄₃ClN₄O₁₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 787.22

Ref: TM-TQ0049